Health & Wellness ArdorComm Media Group

ICMR Has Not Studied Whether Ultra-Processed Foods Show Addiction-Like Behaviour: Centre

admin August 11, 2026

ArdorComm Media News Network

August 11, 2026

The Indian Council of Medical Research (ICMR) has not conducted any study to determine whether ultra-processed foods (UPFs) display addiction-like behavioural characteristics similar to tobacco or other habit-forming substances, the government informed the Lok Sabha. Responding to a written question

ICAR Unveils India’s First Indigenous Vaccine Against African Swine Fever

admin August 6, 2026

ArdorComm Media News Network

August 6, 2026

The Indian Council of Agricultural Research (ICAR) has developed India’s first homegrown vaccine to combat African swine fever (ASF), marking a significant milestone in the country’s efforts to protect livestock from one of the world’s most destructive pig diseases. African

India Accounts for Nearly 70% of South Asia’s Childhood Leukaemia Cases: Lancet Study

admin August 4, 2026

ArdorComm Media News Network

August 4, 2026

India bears the highest burden of childhood leukaemia in South Asia, accounting for nearly 70% of all reported cases in the region, according to a new study published in The Lancet. Researchers attribute the high numbers largely to the country’s

Manipal Health Raises ₹4,167 Crore from Anchor Investors Ahead of ₹9,275-Crore IPO

admin July 30, 2026

ArdorComm Media News Network

July 30, 2026

Manipal Health Enterprises has secured ₹4,167 crore from anchor investors ahead of the launch of its ₹9,275-crore initial public offering (IPO), which opened for public subscription on Wednesday. The IPO witnessed an initial subscription of 6% by 1:30 pm, according

Almost Every Country Overuses Strong Antibiotics, Fueling Drug Resistance: Lancet Study

admin July 27, 2026

ArdorComm Media News Network

July 27, 2026

A new global study has found that nearly every country is overusing powerful antibiotics that are meant to be reserved for severe infections, raising concerns over the growing threat of antimicrobial resistance (AMR). The findings, published in The Lancet Public

Doctors identify simple scoring tool to spot life-threatening risks in premature newborns

admin July 23, 2026

ArdorComm Media News Network

July 23, 2026

Doctors at Sawai Man Singh (SMS) Medical College in Jaipur have found that a simple clinical scoring system can help identify serious health risks in premature and low-birth-weight newborns soon after admission, enabling faster treatment and improving survival prospects. The

FDA Approves First-Ever Cholesterol-Lowering Pill Targeting PCSK9 for High-Risk Patients

admin July 20, 2026

ArdorComm Media News Network

July 20, 2026

The U.S. Food and Drug Administration (FDA) has approved Lipfendra, a groundbreaking oral medication developed by Merck, marking the first pill designed to lower cholesterol by targeting the PCSK9 protein. Until now, this treatment approach was available only through injectable

NMC Announces 1.37 Lakh MBBS Seats for 2026–27; Karnataka Leads Surge in Private Medical College Capacity

admin July 17, 2026

ArdorComm Media News Network

July 17, 2026

The National Medical Commission (NMC) has released the undergraduate (UG) medical seat matrix for the 2026–27 academic session, notifying a total of 1,36,939 MBBS seats across government and private medical colleges in India. The announcement comes as aspirants continue to

Poor Muscle Health Along With Obesity May Significantly Raise Type 2 Diabetes Risk: Study

admin July 16, 2026

ArdorComm Media News Network

July 16, 2026

A combination of poor muscle health and excess body fat may substantially increase the risk of developing type 2 diabetes, according to a new study published in the journal Diabetes Care. Researchers found that individuals with sarcopenic obesity—a condition marked

Novo Nordisk Introduces Once-Weekly Insulin Injection ‘Awiqli’ in India for Adults with Diabetes

admin July 10, 2026

ArdorComm Media News Network

July 10, 2026

Danish pharmaceutical company Novo Nordisk has launched Awiqli, its once-weekly basal insulin injection, in India, offering adults with type 1 and type 2 diabetes an alternative to conventional daily insulin therapy. The company announced the launch on July 9, with

Community Stakeholders

Health & Wellness Community News

ICMR Has Not Studied Whether Ultra-Processed Foods Show Addiction-Like Behaviour: Centre

ICAR Unveils India’s First Indigenous Vaccine Against African Swine Fever

India Accounts for Nearly 70% of South Asia’s Childhood Leukaemia Cases: Lancet Study

Manipal Health Raises ₹4,167 Crore from Anchor Investors Ahead of ₹9,275-Crore IPO

Almost Every Country Overuses Strong Antibiotics, Fueling Drug Resistance: Lancet Study

Doctors identify simple scoring tool to spot life-threatening risks in premature newborns

FDA Approves First-Ever Cholesterol-Lowering Pill Targeting PCSK9 for High-Risk Patients

NMC Announces 1.37 Lakh MBBS Seats for 2026–27; Karnataka Leads Surge in Private Medical College Capacity

Poor Muscle Health Along With Obesity May Significantly Raise Type 2 Diabetes Risk: Study

Novo Nordisk Introduces Once-Weekly Insulin Injection ‘Awiqli’ in India for Adults with Diabetes

Kindly subscribe to our newsletter and stay updated.

Explore more

Contact us

Reach us